Bhatt Padmanabh P.'s Form 4 filing
Supernus Pharmaceuticals, Inc. (SUPN) · filed Mar 14, 2024
- Accession no.
- 0001104659-24-034563
- Filed
- Mar 14, 2024
- Trade date
- Mar 12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $128.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bhatt Padmanabh P.CIK 0001539215 | Officer (Sr. VP of IP, CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 | Common Stock | MOption exerciseAcquired | +3,884 | $12.98 | +$50,414.32 | 12,454 | Direct | |
| Mar 12, 2024 | Common Stock | SSaleDisposed | −3,884 | $32.99 | −$128,133.16 | 8,570 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 | Common Stock | MOption exerciseDisposed | −3,884 | $0.00 | $0 | 36,116 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.